Antony Blanc, PhD

Chief Business Officer and Chief Commercial Officer

Antony Blanc, PhD joined CureVac in December 2020 as Chief Business Officer and Chief Commercial Officer. Previously, he served biotech clients in Europe as an Associate Partner with McKinsey & Company. Between 2009 and 2017, he developed deep and broad cross-functional expertise in vaccines by serving in several senior roles at GSK Vaccines, including leading strategic marketing, strategic pricing, joint ventures and the integration of the Novartis Vaccines business unit. From 2000 to 2009, Blanc held leadership roles at several biotech companies, such as Chief Business Officer at Synosia and Head of Biopharma at Syngenta.


Mr. Blanc started his career at the strategy consulting firm McKinsey & Company in 1994, focusing on pharma and biotech. He holds a Ph.D. in Molecular Biology and a BS.c. in Biochemistry from McGill University in Montreal, Canada.

Back to Executive Board